OnKure Therapeutics (OKUR)

• Market cap: $39M
• 1 day: -3.03%
• 5 days: -8.57%
• 1 month: 21.52%
• 3 months: 15.66%
• 6 months: -1.71%
• Year to date: -66.2%
• 1 year: -84.51%
• 5 years: -97.93%
• 10 years: -97.93%
• Sector: Healthcare
• Industry: Biotechnology

About: OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Employees: 46